Ftse Mib
33.887,05
0,62%
DAX
18.996,63
0,89%
S&P 500
5.726,47
0,14%
NASDAQ
18.059,76
0,48%
Bitcoin
63.791,90
0,73%
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Palisade Bio Inc (PALI) Palisade Bio Inc (PALI) Notizie

PALI

Palisade Bio (PALI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PALI
DataOraFonteTitoloSimboloCompagnia
16/09/202414:00GlobeNewswire Inc.Palisade Bio Launches New Corporate Branding and Reiterates Commitment to Advancing Next-Generation Precision TherapiesNASDAQ:PALIPalisade Bio Inc
05/09/202414:00GlobeNewswire Inc.Palisade Bio Reports Data Demonstrating PDE4B Expression in Patient Cohorts Could be Utilized as a Potential Marker for Patient StratificationNASDAQ:PALIPalisade Bio Inc
19/08/202414:00GlobeNewswire Inc.Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PALIPalisade Bio Inc
13/08/202414:05GlobeNewswire Inc.Palisade Bio Reports Second Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PALIPalisade Bio Inc
12/08/202422:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PALIPalisade Bio Inc
08/08/202414:00GlobeNewswire Inc.Palisade Bio Selects Dose for Upcoming Phase 1 Clinical Study of PALI-2108 for Ulcerative ColitisNASDAQ:PALIPalisade Bio Inc
31/07/202415:15GlobeNewswire Inc.Palisade Bio Participates in Virtual Investor “What this Means” SegmentNASDAQ:PALIPalisade Bio Inc
29/07/202414:30GlobeNewswire Inc.Palisade Bio Successfully Completes Microbiome Study Confirming Bacterial Enzymes for Local Bioactivation of Lead Product Candidate, PALI-2108NASDAQ:PALIPalisade Bio Inc
19/07/202414:30GlobeNewswire Inc.Palisade Bio Announces European Patent Office Issued a Decision to Grant Notice for Patent for Lead Product Candidate, PALI-2108NASDAQ:PALIPalisade Bio Inc
16/07/202402:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
08/07/202423:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PALIPalisade Bio Inc
24/06/202415:00GlobeNewswire Inc.Palisade Bio to Participate in the Virtual Investor Closing Bell SeriesNASDAQ:PALIPalisade Bio Inc
21/06/202414:15GlobeNewswire Inc.Palisade Bio Provides Update on Advancement of its Strategic Collaboration with Strand Life SciencesNASDAQ:PALIPalisade Bio Inc
11/06/202414:30GlobeNewswire Inc.Palisade Bio Announces Notice of Allowance for Canadian Patent Covering Lead Product Candidate, PALI-2108NASDAQ:PALIPalisade Bio Inc
10/06/202415:15GlobeNewswire Inc.Palisade Bio to Present at the Virtual Investor Pitch ConferenceNASDAQ:PALIPalisade Bio Inc
22/05/202422:50Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PALIPalisade Bio Inc
22/05/202422:48Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:PALIPalisade Bio Inc
22/05/202422:45Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PALIPalisade Bio Inc
21/05/202414:30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Local Bioactivation and Dose Dependent Efficacy Response in Preclinical Mouse ModelsNASDAQ:PALIPalisade Bio Inc
20/05/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PALIPalisade Bio Inc
17/05/202422:51Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PALIPalisade Bio Inc
16/05/202422:44Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PALIPalisade Bio Inc
14/05/202414:05GlobeNewswire Inc.Palisade Bio Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:PALIPalisade Bio Inc
10/05/202422:37Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PALIPalisade Bio Inc
08/05/202423:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PALIPalisade Bio Inc
07/05/202414:30GlobeNewswire Inc.Palisade Bio Appoints Margery Fischbein to its Board of DirectorsNASDAQ:PALIPalisade Bio Inc
07/05/202413:30GlobeNewswire Inc.Palisade Bio Announces Closing of $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
02/05/202414:30GlobeNewswire Inc.Palisade Bio Announces $4 Million Private Placement Priced At-The- Market Under Nasdaq RulesNASDAQ:PALIPalisade Bio Inc
01/05/202414:30GlobeNewswire Inc.Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)NASDAQ:PALIPalisade Bio Inc
23/04/202414:30GlobeNewswire Inc.Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine ApproachNASDAQ:PALIPalisade Bio Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:PALI

La tua Cronologia

BIT
UCG
Unicredit
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STMMI
ST Microelectronics
BIT
TEN
Tenaris
BIT
ENEL
Enel
BIT
RACE
Ferrari NV
BIT
MONC
Moncler
BIT
SPM
Saipem
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
PRY
Prysmian
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
IVG
Iveco Group NV
BIT
CPR
Davide Campari
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network